Finally, we identified TRIM24 to be a negative regulator of STAT1 that plays a similar tumorigenic function to STAT1 in vitro and thus may be a potential target when treating HNSCC. This evidence concerns the gene STAT1 and head and neck squamous cell carcinoma.